Switzerland: medical cannabis snapshot

Switzerland lifted its ban on medical cannabis in 2022. Doctors are now given discretion on when cannabis should be prescribed and no longer have to obtain a special permit from the FOPH, though they must provide it with some information about the patient and therapy. Only products with more than 1% THC require a narcotics prescription.

This snapshot offers an overview of Switzerland’s medical cannabis market and its regulations.

I'm already a subscriber

Ana Liz Molina

Market analyst
Ana Liz has a degree in International Relations and a Master’s in Marketing and Market Research from the University of Valencia. She has previously worked as a consultant and analyst in the real estate sector in Central America.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization